Application 062697

Type
ANDA
Sponsor
BAYER PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MEZLINMEZLOCILLIN SODIUM MONOHYDRATEINJECTABLE;INJECTIONEQ 3GM BASE/VIALNoNo
002MEZLINMEZLOCILLIN SODIUM MONOHYDRATEINJECTABLE;INJECTIONEQ 4GM BASE/VIALNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062697-001MEZLINMEZLOCILLIN SODIUM MONOHYDRATEEQ 3GM BASE/VIALINJECTABLE / INJECTION1987-01-22
A062697-002MEZLINMEZLOCILLIN SODIUM MONOHYDRATEEQ 4GM BASE/VIALINJECTABLE / INJECTION1987-01-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 90 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A062697-001MEZLINEQ 3GM BASE/VIALINJECTABLE / INJECTION1987-01-223a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A062697-002MEZLINEQ 4GM BASE/VIALINJECTABLE / INJECTION1987-01-223a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A062697-001MEZLINEQ 3GM BASE/VIALINJECTABLE / INJECTION1987-01-22f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10A062697-002MEZLINEQ 4GM BASE/VIALINJECTABLE / INJECTION1987-01-22f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A062697-001MEZLINEQ 3GM BASE/VIALINJECTABLE / INJECTION1987-01-22e64feba35796…
2022-09-29 23:25 UTC2022-09A062697-002MEZLINEQ 4GM BASE/VIALINJECTABLE / INJECTION1987-01-22e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A062697-001MEZLINEQ 3GM BASE/VIALINJECTABLE / INJECTION1987-01-22cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A062697-002MEZLINEQ 4GM BASE/VIALINJECTABLE / INJECTION1987-01-22cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A062697-001MEZLINEQ 3GM BASE/VIALINJECTABLE / INJECTION1987-01-22a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A062697-002MEZLINEQ 4GM BASE/VIALINJECTABLE / INJECTION1987-01-22a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.